The St. Jude medical cardiac valve in infants and children: Role of anticoagulant therapy
نویسندگان
چکیده
منابع مشابه
The St. Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement.
BACKGROUND From October 1977 to October 2002, 4,480 patients (age range, 17 to 94 years; average, 64 +/- 13 years) underwent single valve replacement with the St. Jude Medical heart valve. Of 2,982 aortic (AVR) and 1,498 mitral valve replacements (MVR), concomitant coronary artery bypass grafting was performed on 42% and 33%, respectively. METHODS Cardiac Surgical Associates has maintained an...
متن کاملthe analysis of the role of the speech acts theory in translating and dubbing hollywood films
از محوری ترین اثراتی که یک فیلم سینمایی ایجاد می کند دیالوگ هایی است که هنرپیش گان فیلم میگویند. به زعم یک فیلم ساز, یک شیوه متأثر نمودن مخاطب از اثر منظوره نیروی گفتارهای گوینده, مثل نیروی عاطفی, ترس آور, غم انگیز, هیجان انگیز و غیره, است. این مطالعه به بررسی این مسأله مبادرت کرده است که آیا نیروی فراگفتاری هنرپیش گان به مثابه ی اعمال گفتاری در پنج فیلم هالیوودی در نسخه های دوبله شده باز تولید...
15 صفحه اولCombined warfarin and antiplatelet therapy after St. Jude Medical valve replacement for mitral valve disease.
OBJECTIVES The clinical effect of combined warfarin and antiplatelet therapy on the incidence of stroke and postoperative complications after mitral (plus aortic) valve replacement was studied and compared with that observed with warfarin therapy alone. BACKGROUND It has been reported that combined warfarin and antiplatelet therapy may be effective but may be associated with an increased hemo...
متن کاملThrombosis of St. Jude medical cardiac valve in the mitral position.
T he St. Jude medical cardiac valve prosthesis is presently undergoing clinical hiaL In dfm trials demonstrated superior hernodynamic properties compared with other clinicaIly available d a c valve pros
متن کاملLong-term outcomes after St. Jude Medical mechanical valve implantation.
patient-year), major bleeding events (1.0%/patient-year), and aortic valve reoperation (0.26%/patient-year). They also reported that valve-related death was the most common cause of death (26.8%) and that the rates of freedom from valve-related death were 96.2%, 92.7%, 88.8%, and 86.6% at 5, 10, 15, and 20 years, respectively. These results compare favorably with the findings of previous report...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 1987
ISSN: 0735-1097
DOI: 10.1016/s0735-1097(87)80108-0